13 results on '"Malleske DT"'
Search Results
2. Childhood Asthma Disparities-Race, Place, or Not Keeping Pace?
- Author
-
Malleske DT, Bryant-Stephens TC, and Montoya-Williams D
- Subjects
- Child, Health Status Disparities, Humans, Asthma epidemiology, Asthma therapy
- Published
- 2022
- Full Text
- View/download PDF
3. Use of Antenatal Corticosteroids for Risk of Preterm Birth-Is Timing Everything?
- Author
-
Duncan AF, Malleske DT, and Maitre NL
- Subjects
- Adrenal Cortex Hormones adverse effects, Female, Gestational Age, Humans, Infant, Newborn, Pregnancy, Prenatal Care, Premature Birth prevention & control
- Published
- 2022
- Full Text
- View/download PDF
4. Assessment of Beta-2 Microglobulin Gene Edited Airway Epithelial Stem Cells as a treatment for Sulfur Mustard Inhalation.
- Author
-
Naeimi Kararoudi M, Alsudayri A, Hill CL, Elmas E, Sezgin Y, Thakkar A, Hester ME, Malleske DT, Lee DA, Neal ML, Perry MR, Harvilchuck JA, and Reynolds SD
- Abstract
Respiratory system damage is the primary cause of mortality in individuals who are exposed to vesicating agents including sulfur mustard (SM). Despite these devastating health complications, there are no fielded therapeutics that are specific for such injuries. Previous studies reported that SM inhalation depleted the tracheobronchial airway epithelial stem cell (TSC) pool and supported the hypothesis, TSC replacement will restore airway epithelial integrity and improve health outcomes for SM-exposed individuals. TSC express Major Histocompatibility Complex (MHC-I) transplantation antigens which increases the chance that allogeneic TSC will be rejected by the patient's immune system. However, previous studies reported that Beta-2 microglobulin (B2M) knockout cells lacked cell surface MHC-I and suggested that B2M knockout TSC would be tolerated as an allogeneic graft. This study used a Cas9 ribonucleoprotein (RNP) to generate B2M-knockout TSC, which are termed Universal Donor Stem Cells (UDSC). Whole genome sequencing identified few off-target modifications and demonstrated the specificity of the RNP approach. Functional assays demonstrated that UDSC retained their ability to self-renew and undergo multilineage differentiation. A preclinical model of SM inhalation was used to test UDSC efficacy and identify any treatment-associated adverse events. Adult male Sprague-Dawley rats were administered an inhaled dose of 0.8 mg/kg SM vapor which is the inhaled LD
50 on day 28 post-challenge. On recovery day 2, vehicle or allogeneic Fisher rat UDSC were delivered intravenously ( n = 30/group). Clinical parameters were recorded daily, and planned euthanasia occurred on post-challenge days 7, 14, and 28. The vehicle and UDSC treatment groups exhibited similar outcomes including survival and a lack of adverse events. These studies establish a baseline which can be used to further develop UDSC as a treatment for SM-induced airway disease., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Naeimi Kararoudi, Alsudayri, Hill, Elmas, Sezgin, Thakkar, Hester, Malleske, Lee, Neal, Perry, Harvilchuck, Reynolds.)- Published
- 2022
- Full Text
- View/download PDF
5. Factors Associated with Neurodevelopmental Impairment in Bronchopulmonary Dysplasia.
- Author
-
Bauer SE, Schneider L, Lynch SK, Malleske DT, Shepherd EG, and Nelin LD
- Subjects
- Child, Preschool, Female, Follow-Up Studies, Gestational Age, Humans, Incidence, Infant, Male, Neurodevelopmental Disorders epidemiology, Ohio epidemiology, Retrospective Studies, Risk Factors, Bronchopulmonary Dysplasia complications, Infant, Premature, Neurodevelopmental Disorders etiology, Risk Assessment methods
- Abstract
Objective: To identify factors associated with neurodevelopmental impairment (NDI) in patients with bronchopulmonary dysplasia (BPD)., Study Design: We identified 151 patients with moderate to severe BPD from 2010 to 2014 with complete Bayley Scales of Infant Development (BSID) scores at 24 months corrected age. We defined NDI as any diagnosis of cerebral palsy or ≥1 BSID composite scores of <80., Results: The mean corrected age at BSID was 23 ± 1 months; 18% had a cognitive score of <80, 37% had a communication score of <80, and 26% had a motor score of <80. Cerebral palsy was diagnosed in 22 patients (15%); 84 (56%) patients did not have NDI. Patients with NDI had lower birth weight, but there was no difference in gestational age at birth, severe intraventricular hemorrhage (IVH), necrotizing enterocolitis, or patent ductus arteriosus ligation compared with patients with no NDI. Ventilator days were greater in patients with NDI than in patients without NDI. More patients with NDI received furosemide and systemic corticosteroids and the hospital length of stay was longer than in patients with no NDI. Logistic regression modeling demonstrated that for every additional 100 g of birth weight the odds of NDI decreased by 35% and for every additional hospital day the odds of NDI increased by 1.3%., Conclusions: In our cohort of patients with moderate to severe BPD, the majority had no NDI, and low birth weight and length of hospital stay were associated with increased risk of developing NDI. This finding suggests that there are potentially modifiable factors associated with better neurodevelopmental outcomes in patients with BPD that deserve further study., (Copyright © 2019. Published by Elsevier Inc.)
- Published
- 2020
- Full Text
- View/download PDF
6. Detection of Cytomegalovirus in Intestinal Tissue of Infants with Necrotizing Enterocolitis or Spontaneous Intestinal Perforation.
- Author
-
Panesso-Gómez S, Shimamura M, Conces M, Talavera MM, Moallem M, Sánchez PJ, and Malleske DT
- Subjects
- Cytomegalovirus Infections diagnosis, Cytomegalovirus Infections epidemiology, Female, Humans, Infant, Infant, Newborn, Male, Retrospective Studies, Cytomegalovirus isolation & purification, Cytomegalovirus Infections complications, Enterocolitis, Necrotizing virology, Intestinal Perforation virology, Intestine, Small virology
- Abstract
Objective: To determine the frequency of detection of cytomegalovirus (CMV) in surgical or autopsy intestinal tissue from infants with necrotizing enterocolitis (NEC) or spontaneous intestinal perforation (SIP) of the small bowel., Study Design: This was a retrospective cohort study of infants in the neonatal intensive care unit at Nationwide Children's Hospital, Columbus, Ohio, with NEC (Bell stage ≥2B) or SIP from 2000 to 2016. Paraffin-embedded surgical or autopsy intestinal tissues were examined for CMV by polymerase chain reaction (PCR) and immunohistochemistry (IHC), and clinical characteristics of CMV-positive vs CMV-negative cases were compared., Results: CMV was detected by PCR or IHC in 7 (4%) of 178 infants with surgical or autopsy- confirmed NEC (n = 6) or SIP (n = 1). Among 143 NEC cases (123 surgical, 20 autopsy), CMV was detected in 6 (4%): 4 (2 surgical, 2 autopsy) by both PCR and IHC, and 2 (surgical) by PCR only. Among 35 SIP cases (32 surgical, 3 autopsy), 1 (3%) surgical case was positive, by PCR only. CMV-associated NEC cases had lower median gestational age (24 vs 28 weeks; P = .02), birth weight (649 vs 1121 g; P = .04), and platelet count (16 000/mm
3 vs 50 000/mm3 ; P = .018) compared with CMV-negative cases, respectively. No association was found with receipt of maternal milk, age at NEC diagnosis, male sex, cholestasis, or mortality., Conclusions: CMV was detected in intestinal tissue from 4% of NEC or SIP cases (NEC, 4%; SIP, 3%). Lower gestational age, lower birth weight, and thrombocytopenia were significantly associated with detection of CMV in NEC or SIP cases., (Copyright © 2019 Elsevier Inc. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
7. Regulation of Human Airway Epithelial Tissue Stem Cell Differentiation by β-Catenin, P300, and CBP.
- Author
-
Malleske DT, Hayes D Jr, Lallier SW, Hill CL, and Reynolds SD
- Subjects
- Adolescent, Adult, Animals, Bridged Bicyclo Compounds, Heterocyclic pharmacology, Bronchi cytology, Bronchi metabolism, Cell Differentiation physiology, Cell Line, Tumor, Chronic Disease, E1A-Associated p300 Protein antagonists & inhibitors, Epithelial Cells cytology, Epithelial Cells metabolism, Epithelial Cells pathology, Heterocyclic Compounds, 3-Ring pharmacology, Humans, Lung Diseases pathology, Mice, Mice, Knockout, Middle Aged, Peptide Fragments antagonists & inhibitors, Pyridines pharmacology, Pyrimidines pharmacology, Pyrimidinones pharmacology, Respiratory Mucosa metabolism, Respiratory Mucosa pathology, Sialoglycoproteins antagonists & inhibitors, Stem Cells metabolism, Stem Cells pathology, Young Adult, beta Catenin agonists, beta Catenin antagonists & inhibitors, E1A-Associated p300 Protein metabolism, Lung Diseases metabolism, Peptide Fragments metabolism, Respiratory Mucosa cytology, Sialoglycoproteins metabolism, Stem Cells cytology, beta Catenin metabolism
- Abstract
The wingless/integrase-1 (WNT)/β-catenin signaling pathway is active in several chronic lung diseases including idiopathic pulmonary fibrosis, asthma, and chronic obstructive pulmonary disease. Although this WNT/β-catenin pathway activity is associated with an increase in mucus cell frequency and a decrease in ciliated cell frequency, a cause and consequence relationship between signaling and cell frequency has not been established. We previously demonstrated that genetic stabilization of β-catenin inhibited differentiation of mouse bronchiolar tissue stem cells (TSC). This study determined the effect of β-catenin and its co-factors P300 (E1A-binding protein, 300 kDa) and cAMP response element binding (CREB)-binding protein (CBP) on human bronchial epithelial TSC differentiation to mucus and ciliated cells. We developed a modified air-liquid interface (ALI) culture system in which mucus and ciliated cell frequency is similar. These cultures were treated with the β-catenin agonist CHIR99021 (CHIR) and antagonists to β-catenin (XAV939), P300 (IQ1), and CBP (ICG001). We report that human TSC differentiation to mucus and ciliated cells can be divided into two stages, specification and commitment. CHIR treatment inhibited mucus and ciliated cell commitment while XAV939 treatment demonstrated that β-catenin was necessary for mucus and ciliated cell specification. Additional studies demonstrate that a β-catenin/P300 complex promotes mucus cell specification and that β-catenin interacts with either P300 or CBP to inhibit ciliated cell commitment. These data indicate that activation of β-catenin-dependent signaling in chronic lung disease leads to changes in mucus and ciliated cell frequency and that P300 and CBP tune the β-catenin signal to favor mucus cell differentiation. Stem Cells 2018;36:1905-12., (©AlphaMed Press 2018.)
- Published
- 2018
- Full Text
- View/download PDF
8. Infant Pulmonary Function Testing and Phenotypes in Severe Bronchopulmonary Dysplasia.
- Author
-
Shepherd EG, Clouse BJ, Hasenstab KA, Sitaram S, Malleske DT, Nelin LD, and Jadcherla SR
- Subjects
- Bronchodilator Agents therapeutic use, Bronchopulmonary Dysplasia drug therapy, Cohort Studies, Female, Humans, Infant, Extremely Low Birth Weight, Infant, Extremely Premature, Infant, Newborn, Infant, Small for Gestational Age, Intensive Care Units, Neonatal, Logistic Models, Male, Phenotype, Bronchopulmonary Dysplasia classification, Bronchopulmonary Dysplasia physiopathology, Forced Expiratory Volume physiology, Total Lung Capacity physiology
- Abstract
Background: The definition of severe bronchopulmonary dysplasia (sBPD) is based on respiratory support needs. The management of a patient with sBPD remains empirical and is highly variable among providers. Our objective in this study was to test the hypothesis that infant pulmonary function testing (iPFT) would reveal distinct phenotypes in patients with established sBPD during the initial NICU stay., Methods: A prospective cohort study with data prospectively collected on infants with sBPD from May 1, 2003, to June 30, 2016. iPFT data were used to classify the patients as obstructive, restrictive, or mixed., Results: The median gestational age at birth was 25 weeks (interquartile range [IQR], 24-27 weeks) and the median birth weight was 707 g (IQR, 581-925 g). At the time of iPFT, the median postmenstrual age was 52 weeks (IQR, 45-63 weeks), and the median weight was 4.4 kg (IQR, 3.7-6.0 kg). There were 56 (51%) patients with obstructive, 44 (40%) with mixed, and 10 (9%) with restrictive phenotypes. Moderate or severe obstruction was seen in 86% of the obstructive group and 78% of the mixed group. Of the restrictive patients, 70% had moderate and 30% had mild restriction. Bronchodilator response was seen in 74% of obstructive, 63% of mixed, and 25% of restrictive patients., Conclusions: Our findings reveal that sBPD as it is currently defined includes distinct phenotypes. Future researchers of diagnostic approaches to this population should consider the development of bedside tests to define phenotypes, and researchers in future therapeutic trials should consider the use of pulmonary function phenotyping in patient recruitment., Competing Interests: POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose., (Copyright © 2018 by the American Academy of Pediatrics.)
- Published
- 2018
- Full Text
- View/download PDF
9. Pulmonary sequelae and functional limitations in children and adults with bronchopulmonary dysplasia.
- Author
-
Malleske DT, Chorna O, and Maitre NL
- Subjects
- Adult, Child, Exercise Tolerance, Humans, Physical Conditioning, Human methods, Respiratory Function Tests methods, Time, Bronchopulmonary Dysplasia diagnosis, Bronchopulmonary Dysplasia physiopathology, Bronchopulmonary Dysplasia rehabilitation
- Abstract
Preterm infants with bronchopulmonary dysplasia (BPD) often suffer from life-long pulmonary impairments in pulmonary physical function. This review summarizes our current understanding of the chronic pulmonary impairments and physical functional limitations associated with BPD from preterm birth to adulthood. It also identifies opportunities for intervention in children and adults living with chronic lung disease (CLD) after preterm birth., (Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
10. Measuring End-Tidal Carbon Monoxide of Jaundiced Neonates in the Birth Hospital to Identify Those with Hemolysis.
- Author
-
Christensen RD, Malleske DT, Lambert DK, Baer VL, Prchal JT, Denson LE, Gerday E, Weaver Lewis KA, and Shepherd JG
- Subjects
- Birthing Centers, Breath Tests, Female, Hematologic Tests, Heme analysis, Humans, Infant, Newborn, Male, Prospective Studies, United States, Bilirubin blood, Carbon Monoxide analysis, Hemolysis, Hyperbilirubinemia diagnosis, Jaundice, Neonatal diagnosis
- Abstract
Background: End-tidal breath carbon monoxide (ETCOc) levels correlate with catabolism of heme, but until recently, this measurement was not readily available for application to neonatology practice., Objectives: We performed a prospective, multihospital, test-of-concept study where ETCOc was measured during the birth hospitalization of neonates with a total bilirubin (TB) value >75th percentile on the Bhutani bilirubin nomogram. This was done to test the feasibility and ease of use of this new device., Methods: Neonates with an elevated ETCOc (with a >95th percentile reference interval previously established) were labeled as having 'hemolytic jaundice'. We recommended a follow-up TB check <24 h after hospital discharge to these families., Results: One hundred and fifteen neonates were eligible for the study, the parents of 103 provided consent, and measurements were obtained for 100. Sixty-three had normal and 37 had elevated ETCOc values. By means of a direct antiglobulin test (DAT; Coombs), 11 of these 37 were found positive for ABO hemolytic disease; the remaining 26 had other etiologies. Thirty-six of the 37 with an elevated ETCOc had repeat TB monitoring <24 h after discharge home. None of the 100 were rehospitalized for jaundice treatment compared with a rate of 2.99 rehospitalizations per 100 control neonates who had a TB value >75th percentile (p = 0.079)., Conclusion: ETCOc measurement is a feasible means of assessing hemolysis in jaundiced neonates during the birth hospitalization. When hemolysis is identified, parents are likely to comply with instructions to bring the infant for a TB checkup <24 h after discharge home., (© 2015 S. Karger AG, Basel.)
- Published
- 2016
- Full Text
- View/download PDF
11. Congenital chylothorax treated with oral sildenafil: a case report and review of the literature.
- Author
-
Malleske DT and Yoder BA
- Subjects
- Chylothorax drug therapy, Female, Humans, Infant, Newborn, Infant, Premature, Diseases drug therapy, Lung diagnostic imaging, Lung Diseases diagnosis, Lung Diseases drug therapy, Lymphangiectasis diagnosis, Lymphangiectasis drug therapy, Tomography, X-Ray Computed, Chylothorax congenital, Lung Diseases congenital, Lymphangiectasis congenital, Phosphodiesterase 5 Inhibitors administration & dosage, Sildenafil Citrate administration & dosage
- Abstract
Congenital chylothorax (CC) can result from a congenital malformation or an acquired obstruction or disruption of the thoracic duct. Recently, oral administration of the phosphodiesterase-5 inhibitor, sildenafil, was reported to be effective in resolving non-pulmonary lymphatic malformations in infants and young children. We report a case of CC in a late preterm infant with congenital pulmonary lymphangiectasia where octreotide was not effective, but management with oral sildenafil was successful.
- Published
- 2015
- Full Text
- View/download PDF
12. Lung heparan sulfates modulate K(fc) during increased vascular pressure: evidence for glycocalyx-mediated mechanotransduction.
- Author
-
Dull RO, Cluff M, Kingston J, Hill D, Chen H, Hoehne S, Malleske DT, and Kaur R
- Subjects
- Animals, Atrial Function, Left drug effects, Blood Pressure, Glucuronidase pharmacology, Glycocalyx metabolism, Heparitin Sulfate metabolism, In Vitro Techniques, Lung drug effects, Lung metabolism, Male, NG-Nitroarginine Methyl Ester pharmacology, Nitric Oxide metabolism, Nitric Oxide Synthase Type III antagonists & inhibitors, Nitric Oxide Synthase Type III metabolism, Permeability drug effects, Porphyrins pharmacology, Pulmonary Ventilation, Rats, Rats, Sprague-Dawley, S-Nitrosoglutathione pharmacology, Tidal Volume, Tyrosine analogs & derivatives, Tyrosine metabolism, Glycocalyx physiology, Heparitin Sulfate physiology, Lung physiology, Mechanotransduction, Cellular
- Abstract
Lung endothelial cells respond to changes in vascular pressure through mechanotransduction pathways that alter barrier function via non-Starling mechanism(s). Components of the endothelial glycocalyx have been shown to participate in mechanotransduction in vitro and in systemic vessels, but the glycocalyx's role in mechanosensing and pulmonary barrier function has not been characterized. Mechanotransduction pathways may represent novel targets for therapeutic intervention during states of elevated pulmonary pressure such as acute heart failure, fluid overload, and mechanical ventilation. Our objective was to assess the effects of increasing vascular pressure on whole lung filtration coefficient (K(fc)) and characterize the role of endothelial heparan sulfates in mediating mechanotransduction and associated increases in K(fc). Isolated perfused rat lung preparation was used to measure K(fc) in response to changes in vascular pressure in combination with superimposed changes in airway pressure. The roles of heparan sulfates, nitric oxide, and reactive oxygen species were investigated. Increases in capillary pressure altered K(fc) in a nonlinear relationship, suggesting non-Starling mechanism(s). nitro-l-arginine methyl ester and heparanase III attenuated the effects of increased capillary pressure on K(fc), demonstrating active mechanotransduction leading to barrier dysfunction. The nitric oxide (NO) donor S-nitrosoglutathione exacerbated pressure-mediated increase in K(fc). Ventilation strategies altered lung NO concentration and the K(fc) response to increases in vascular pressure. This is the first study to demonstrate a role for the glycocalyx in whole lung mechanotransduction and has important implications in understanding the regulation of vascular permeability in the context of vascular pressure, fluid status, and ventilation strategies.
- Published
- 2012
- Full Text
- View/download PDF
13. Hyperoxia increases hepatic arginase expression and ornithine production in mice.
- Author
-
Malleske DT, Rogers LK, Velluci SM, Young TL, Park MS, Long DW, Welty SE, Smith CV, and Nelin LD
- Subjects
- Animals, Citrulline metabolism, Glutathione metabolism, Glutathione Disulfide metabolism, Glutathione Peroxidase metabolism, Glutathione Reductase, Liver metabolism, Mice, Mice, Inbred C3H, Nitric Oxide Synthase Type II metabolism, Nitric Oxide Synthase Type III metabolism, Arginase metabolism, Hyperoxia enzymology, Liver enzymology, Ornithine biosynthesis
- Abstract
Hyperoxic exposure affects the levels and activities of some hepatic proteins. We tested the hypothesis that hyperoxic exposure would result in greater hepatic .NO concentrations. C3H/HeN mice were exposed to >95% O(2) for 72 or 96 h and compared to room air-breathing controls. In contrast to our working hypothesis, exposure to >95% O(2) for 96 h decreased hepatic nitrite/nitrate NO(X) concentrations (10.9 +/- 2.2 nmol/g liver versus 19.3 +/- 2.4 nmol/g liver in room air, P < 0.05). The hepatic levels of endothelial NO synthase (eNOS) and inducible NOS (iNOS) proteins were not different among the groups. The arginases, which convert L-arginine to urea and L-ornithine, may affect hepatic NOS activities by decreasing L-arginine bioavailability. Hepatic ornithine concentrations were greater in hyperoxic animals than in controls (318 +/- 18 nmol/g liver in room air, and 539 +/- 64, and 475 +/- 40 at 72 and 96 h of hyperoxia, respectively, P < 0.01). Hepatic arginase I protein levels were greater in hyperoxic animals than in controls. Hepatic carbamoyl phosphate synthetase (CPS) protein levels and activities were not different among groups. These results indicate that increases in hepatic levels of arginase I in mice exposed to hyperoxia may diminish .NO production, as reflected by lower liver levels of NO(X). The resultant greater hepatic ornithine concentrations may represent a mechanism to facilitate tissue repair, by favoring the production of polyamines and/or proline.
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.